VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
JBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
JBSJbs N.V.
$13.14$28.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksJBSCash Flow

Jbs N.V. (JBS) Cash Flow Statement

12Y historyFree accessUpdated daily

Free cash flow swung from $6.0B in 2025Q4 to -$7.0B in 2026Q1, with working capital outflows of $7.1B in 2026Q1 and capital expenditures peaking at 13.2% of revenue, while dividends and buybacks totaled $5.4B and $10.3B respectively.

Income StatementBalance SheetCash FlowRatios

JBS Cash Flow Statement

Annual statement

JBS Cash Flow Statement

Jbs N.V. (JBS) cash flow statement — 12-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Cash from Operations13.09B15.49B23.56B11.5B13.33B21.48B23.78B13.77B7.44B5.2B3.67B7.38B8.99B
Operating CF Margin %-3.29%5.65%3.16%3.47%5.93%8.8%6.73%4.1%3.19%2.15%4.53%7.46%
Operating CF Growth %-107.96%-34.23%104.87%-13.76%-37.93%-9.68%72.73%85%43.02%41.9%-50.34%-17.83%-
Net Income6.41B11.1B9.62B-1.06B15.46B20.49B4.6B6.07B25.2M534.2M233.56M4.64B2.04B
Depreciation & Amortization11.79B12.63B11.81B10.73B9.85B9.03B7.84B6.31B4.8B4.47B4.5B3.69B2.55B
Stock-Based Compensation46.49M085.6M34.42M39.13M63.43M-5.25M49.19M118.11M122.64M143.3M39.74M13.01M
Deferred Taxes1.24B-361.42M00000000000
Other Non-Cash Items-494.09M3.99B9.39B-1.61B-3.16B12.74B13.37B4.71B4.52B1.95B599.92M-190.33M4.94B
Working Capital Changes-5.94B-11.86B-7.34B3.41B-8.85B-20.84B-2.02B-3.37B-2.02B-1.87B-1.81B-797.57M-548.12M
Change in Receivables-981.52M-1.45B-2.02B3.13B-1.3B-4.27B778.49M-259.22M673.18M-234.03M-225.97M1.05B241.82M
Change in Inventory-2.94B-4.58B-4.73B-300.66M-6.78B-11.79B-3.53B-3.13B-2.13B-1.06B-1.16B-866.69M-1.61B
Change in Payables2.87B3.01B00000000000
Cash from Investing-11.15B-12.56B-7.73B-7.02B-13.12B-18.86B-7.83B-5.85B-1.74B-2.43B-3.54B-20.76B-4.28B
Capital Expenditures-10.98B-11.4B-8.08B-7.49B-11.23B-9.62B-5.99B-4.24B-2.83B-3.11B-3.48B-5.45B-3.57B
CapEx % of Revenue2.87%2.42%1.94%2.06%2.92%2.65%2.22%2.07%1.56%1.91%2.04%3.35%2.96%
Acquisitions156.59M394.77M-31.46M-17.16M-1.98B-9.34B-2.19B-2.24B-45.07M-1.85B-482.54M-15.47B0
Investments-------------
Other Investing-211.44M-285.38M382.02M485.19M81.04M102.65M339.15M625.42M1.13B2.53B423.38M169.72M-707.41M
Cash from Financing2.9B-9.97B-7.3B5.01B-8.76B-844.5M-9.02B-6.44B-9.99B-634.37M-8.1B15.17B876.88M
Debt Issued (Net)9.19B7.15B-1.65B7.45B264.71M17.73B-5.6B-6.4B-9.5B-328.63M745.56M9B1.15B
Equity Issued (Net)-11.63B-3.19B-44.49M0-3.65B-10.6B-1.27B0-498.19M-255.94M-821.14M-1.78B-64.23M
Dividends Paid-781.51M-8.81B-4.44B-2.22B-4.44B-7.4B-1.44B-5.98M-126.88M-93.35M-1.1B-482.73M-219.88M
Share Repurchases-11.63B-3.19B-44.49M0-3.65B-10.6B-1.27B0-498.19M-255.94M-821.14M-1.78B-64.23M
Other Financing6.12B-5.12B-1.16B-218.37M-939.51M-575.4M-712.53M-38.77M135.29M43.55M-6.92B8.42B7.03M
Net Change in Cash4.76B-5.71B12.64B8.94B-10.06B3.56B9.65B1.1B-2.81B2.39B-9.49B3.93B14.91B
Free Cash Flow2.14B4.13B15.47B4.01B2.11B11.86B17.8B9.53B4.62B2.09B187.16M1.93B5.42B
FCF Margin %0.56%0.88%3.71%1.1%0.55%3.27%6.59%4.66%2.54%1.28%0.11%1.19%4.5%
FCF Growth %-71.62%-73.32%286.2%90.15%-82.23%-33.37%86.75%106.46%120.61%1017.79%-90.31%-64.35%-
FCF per Share2.093.866.981.810.934.786.703.571.730.740.070.671.88
FCF Conversion (FCF/Net Income)0.33x1.40x2.45x-10.84x0.84x1.01x5.17x2.27x295.35x9.74x15.70x1.59x4.41x
Interest Paid443.97M08.02B6.44B4.8B3.94B3.5B3.6B4.4B3.91B4.12B4.14B0
Taxes Paid181.82M000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High leverage and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q2)

Earnings Quality Diverges Sharply

In 2026Q2, operating cash flow of $4.2B contrasted with a net loss of $102.1M, yielding an OCF/NI of -41.5, per the cash flow statement, indicating significant non-cash adjustments.

The negative net income alongside positive operating cash flow suggests that depreciation and amortization ($3.3B) and working capital changes are masking underlying operational losses. This divergence may indicate that reported earnings are not a reliable indicator of cash generation, and investors should monitor whether this pattern persists.

Free Cash Flow Volatility Intensifies

Free cash flow swung from $6.0B in 2025Q4 to -$7.0B in 2026Q1, with FCF margin dropping from 4.7% to -6.3%, based on reported quarterly data, highlighting extreme quarter-to-quarter instability.

The erratic FCF pattern, including a negative print in 2026Q1, suggests that the company's cash generation is highly sensitive to working capital swings and capex timing. This volatility may complicate debt servicing and capital allocation, especially given the elevated leverage ratio of 2.40.

Capital Intensity Pressures Cash Flow

Capital expenditures averaged $2.6B per quarter over the last ten quarters, with CapEx/Revenue peaking at 13.2% in 2026Q2, as per the cash flow data, indicating rising investment needs amid revenue contraction.

The elevated capex relative to revenue, particularly in the latest quarter, suggests that JBS is maintaining or expanding its asset base despite declining sales. This may reflect maintenance requirements or strategic investments, but it consumes cash that could otherwise be used for debt reduction, given the strained balance sheet.

Working Capital Swings Dominate Cash Flow

Working capital changes were negative in seven of the last ten quarters, with a $7.1B outflow in 2026Q1, according to the cash flow statement, indicating significant cash absorption from operations.

The persistent negative working capital changes, especially the large outflow in 2026Q1, suggest that JBS is experiencing inventory build-ups or delayed collections, possibly due to market disruptions. This pattern may indicate inefficiencies in managing receivables and inventory, which could strain liquidity if not reversed.

Dividends and Buybacks Strain Cash

Dividends paid totaled $5.4B in 2026Q2, while buybacks reached $10.3B in 2025Q3, based on the cash flow data, indicating aggressive shareholder returns despite negative free cash flow in some quarters.

The substantial cash outflows for dividends and buybacks, particularly in quarters with negative FCF, suggest that JBS is prioritizing shareholder returns over balance sheet repair. This may increase financial risk given the high debt levels and could limit flexibility if earnings remain under pressure.

Cumulative Earnings vs Cash Gap Widens

Over the last ten quarters, cumulative net income totaled $21.2B while operating cash flow reached $39.8B, per the cash flow data, indicating a positive cumulative gap of $18.6B.

The cumulative excess of operating cash flow over net income suggests that earnings are being conservatively stated, possibly due to large non-cash charges like depreciation. However, the recent quarters show a reversal, with net income turning negative, which may signal that the historical cash flow advantage is eroding.

What Could Invalidate the Base Case

The 2026Q2 revenue collapse and negative EPS suggest that the company may be facing a structural break, not just cyclical headwinds, which could challenge the narrative of a diversified global protein platform.

The cash flow statement may obscure the severity of operational deterioration through large non-cash adjustments and working capital timing. Investors should scrutinize whether the positive operating cash flow in 2026Q2 is sustainable or merely a result of aggressive working capital management, as the underlying earnings power appears strained.

JBS — Frequently Asked Questions

Quick answers to the most common questions about buying JBS stock.

How much cash does Jbs N.V. (JBS) generate from operations?

Jbs N.V. (JBS) generated $15.49B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Jbs N.V.'s free cash flow?

Jbs N.V. (JBS) generated $4.13B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Jbs N.V.'s capital expenditure (CapEx)?

Jbs N.V. (JBS) spent $11.40B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Jbs N.V. distribute cash to shareholders?

In 2025, Jbs N.V. (JBS) returned $8.81B to shareholders via cash dividends and spent $3.19B on share repurchases. This shows the company's commitment to returning capital to its equity investors.